SCHEMBL8301745

SCHEMBL8301745

CCN1C(=O)c2cccnc2Nc2ncccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.54
SMN1; SMN2 Q16637 6/20 0.48
CASP1 P29466 3/20 0.48
HPGD P15428 1/20 0.48
MPI P34949 1/20 0.48
CACNA1B Q00975 1/20 0.48
APBA1 Q02410 1/20 0.48
CYP1A2 P05177 2/20 0.42
BRD4 O60885 1/20 0.41
CYP1B1 Q16678 1/20 0.41
HSD17B10 Q99714 1/20 0.40
PKM P14618 3/20 0.40
CASP7 P55210 2/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
APAF1 O14727 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790081 0.87 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9431569 0.87 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9368959 0.84 AKT1 (0.47) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9010372 0.82 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2CYP1A2BRD4HSD17B10
SCHEMBL8304689 0.81 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2CYP1A2BRD4HSD17B10
SCHEMBL8791229 0.81 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8791085 0.80 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8792456 0.77 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2CYP1A2MAPTGAA
SCHEMBL8791600 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8789845 0.76 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2CYP1A2MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0393529-B1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1993-06-30 EP disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed
EP-0393529-A1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1990-10-24 EP disclosed